| Literature DB >> 35218826 |
Kadir Yanaç1, Adeola Adegoke2, Liqun Wang2, Miguel Uyaguari3, Qiuyan Yuan4.
Abstract
Although numerous studies have detected SARS-CoV-2 RNA in wastewater and attempted to find correlations between the concentration of SARS-CoV-2 RNA and the number of cases, no consensus has been reached on sample collection and processing, and data analysis. Moreover, the fate of SARS-CoV-2 in wastewater treatment plants is another issue, specifically regarding the discharge of the virus into environmental settings and the water cycle. The current study monitored SARS-CoV-2 RNA in influent and effluent wastewater samples with three different concentration methods and sludge samples over six months (July to December 2020) to compare different virus concentration methods, assess the fate of SARS-CoV-2 RNA in wastewater treatment plants, and describe the potential relationship between SARS-CoV-2 RNA concentrations in influent and infection dynamics. Skimmed milk flocculation (SMF) resulted in 15.27 ± 3.32% recovery of an internal positive control, Armored RNA, and a high positivity rate of SARS-CoV-2 RNA in stored wastewater samples compared to ultrafiltration methods employing a prefiltration step to eliminate solids in fresh wastewater samples. Our results suggested that SARS-CoV-2 RNA may predominate in solids, and therefore, concentration methods focusing on both supernatant and solid fractions may result in better recovery. SARS-CoV-2 RNA was detected in influent and primary sludge samples but not in secondary and final effluent samples, indicating a significant reduction during primary and secondary treatments. SARS-CoV-2 RNA was first detected in influent on September 30th, 2020. A decay-rate formula was applied to estimate initial concentrations of late-processed samples with SMF. A model based on shedding rate and new cases was applied to estimate SARS-CoV-2 RNA concentrations and the number of active shedders. Inferred sensitivity of observed and modeled concentrations to the fluctuations in new cases and test-positivity rates indicated a potential contribution of newly infected individuals to SARS-CoV-2 RNA loads in wastewater.Entities:
Keywords: Back-trajectory modeling; SARS-CoV-2; Virus concentration; Wastewater solids; Wastewater surveillance
Mesh:
Substances:
Year: 2022 PMID: 35218826 PMCID: PMC8864809 DOI: 10.1016/j.scitotenv.2022.153906
Source DB: PubMed Journal: Sci Total Environ ISSN: 0048-9697 Impact factor: 10.753
Delay in sample processing collected from NESTP, SESTP, and WESTP.
| Sampling date | Delay in sample processing (days) |
|---|---|
| November 16, 2020 | 75 |
| November 18, 2020 | 73 |
| December 1, 2020 | 60 |
| December 8, 2020 | 53 |
| December 15, 2020 | 46 |
Reported decay rate characteristics of the SARS-CoV-2 RNA in untreated wastewater at 4 °C.
| Assay | Decay rate (k) | R2 | T50 (days) | T90 (days) | T99 (days) | Reference |
|---|---|---|---|---|---|---|
| N1 | 0.084 ± 0.013 | 0.79 | 27.8 ± 4.45 | ( | ||
| N2 | 0.06 ± 0.0 | 0.99 | 11 | 36.00 | 73.00 | ( |
Fig. 1Percent recovery and statistical analysis for each method.
Concentration of SARS-CoV-2 RNA in influents of three WWTPs. Influent samples collected between November 16th and December 15th (shown in a box) were late processed samples with SMF.
| Sampling date | NESTP | SESTP | WESTP | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Influent (GC/L) | Primary sludge (GC/mL) | Effluent (GC/L) | Influent (GC/L) | Primary sludge (GC/mL) | Effluent (GC/L) | Influent (GC/L) | Primary sludge (GC/mL) | Effluent (GC/L) | ||||||||||
| N1 | N2 | N1 | N2 | N1 | N2 | N1 | N2 | N1 | N2 | N1 | N2 | N1 | N2 | N1 | N2 | N1 | N2 | |
| 8-Jul | 0 | 0 | – | – | 0 | 0 | 0 | 0 | – | – | 0 | 0 | 0 | 0 | – | – | 0 | 0 |
| 22-Jul | 0 | 0 | – | – | 0 | 0 | 0 | 0 | – | – | 0 | 0 | 0 | 0 | – | – | 0 | 0 |
| 5-Aug | 0 | 0 | – | – | 0 | 0 | 0 | 0 | – | – | 0 | 0 | 0 | 0 | – | – | 0 | 0 |
| 19-Aug | 0 | 0 | – | – | 0 | 0 | 0 | 0 | – | – | 0 | 0 | 0 | 0 | – | – | 0 | 0 |
| 2-SeP | 0 | 0 | – | – | 0 | 0 | 0 | 0 | – | – | 0 | 0 | 0 | 0 | – | – | 0 | 0 |
| 16-Sep | 0 | 0 | – | – | 0 | 0 | 0 | 0 | – | – | 0 | 0 | 0 | 0 | – | – | 0 | 0 |
| 30-Sep | 6087 | 25,713 | – | – | 0 | 0 | 8778 | 20,009 | – | – | 0 | 0 | 25,087 | 47,557 | – | – | 0 | 0 |
| 14-Oct | 13,222 | 34,751 | – | – | 0 | 0 | 26,670 | 47,714 | – | – | 0 | 0 | 28,894 | 47,226 | – | – | 0 | 0 |
| 28-Oct | 0 | 0 | – | – | 0 | 0 | 7544 | 21,084 | – | – | 0 | 0 | 0 | 0 | – | – | 0 | 0 |
| 12-Nov | 3.3E+6 | 2.5E+6 | 7980 | 4960 | – | – | 1.2E+6 | 3.4E+6 | 3140 | 2740 | – | – | 9.6E+5 | 1.1E+6 | 2080 | 660 | – | – |
| 16-Nov | 51,400 | 26,668 | 96,200 | 8860 | – | – | 12,964 | 17,410 | 2400 | 1360 | – | – | 16,506 | 4372 | 0 | 0 | – | – |
| 18-Nov | 16,249 | 55,512 | 8540 | 6480 | – | – | 5843 | 17,412 | 3280 | 3040 | – | – | 13,762 | 11,844 | 0 | 380 | – | – |
| 1-Dec | 20,980 | 16,833 | 7480 | 6740 | – | – | 11,261 | 6780 | 3100 | 2260 | – | – | 5519 | 2214 | 0 | 260 | – | – |
| 8-Dec | 15,722 | 11,463 | 12,580 | 5860 | – | – | 4984 | 9685 | 7560 | 2760 | – | – | 9007 | 5300 | 820 | 180 | – | – |
| 15-Dec | 20,371 | 13,120 | 3220 | 1400 | – | – | 17,209 | 8188 | 3020 | 740 | – | – | 5535 | 5211 | 5660 | 2600 | – | – |
Fig. 2Detection of SARS-CoV-2 RNA in influent samples with different concentration methods. Filled shapes represent the samples that are SARS-CoV-2 RNA positive, i.e. CT is <40.
SARS-CoV-2 RNA concentration in influent solids from NESTP, SESTP and WESTP.
| Date | NESTP | SESTP | WESTP | |||
|---|---|---|---|---|---|---|
| N1 (GC/L) | N2 (GC/L) | N1 (GC/L) | N2 (GC/L) | N1 (GC/L) | N2 (GC/L) | |
| 2-Sep | 0 | 0 | 0 | 0 | 0 | 0 |
| 16-Sep | 0 | 0 | 0 | 0 | 0 | 0 |
| 30-Sep | – | – | 232,059 | 367,283 | 75,185 | 0 |
| 14-Oct | 75,422 | 0 | 76,814 | 0 | 0 | 0 |
| 12-Nov | 335,397 | 516,635 | 149,704 | 95,908 | 49,617 | 78,529 |
| 16-Nov | 302,821 | 113,570 | 0 | 26,192 | 159,752 | 29,619 |
| 18-Nov | 626,217 | 242,533 | 128,595 | 42,033 | 307,246 | 147,921 |
| 1-Dec | 43,106 | 26,877 | 69,835 | 49,772 | 120,428 | 60,634 |
| 8-Dec | 45,194 | 21,513 | 31,191 | 14,206 | 15,026 | 12,649 |
| 15-Dec | – | – | – | – | – | – |
Fig. 3COVID-19 infection dynamics in Winnipeg. Temporal changes in the numbers of new, active, and cumulative cases and five-day test positivity rate during sampling period.
Fig. 4Modeled (purple squares), observed (filled red triangles and black circles) and estimated (red triangles and black circles) concentrations of SARS-CoV-2 RNA as log10 concentrations and COVID-19 infection dynamics from the beginning of the outbreak in Winnipeg. Observed concentrations between September 30th and November 12th are the sum of the concentration in solids and filtrates since the latter concentrations were obtained using SMF which concentrates viruses from both supernatant and solids. Estimated concentrations between November 16th and December 15th are calculated using Eq. 3. Observed concentrations are represented for both N1 (filled red triangles) and N2 (filled black circles). Green x represents new cases in Winnipeg corrected with an ascertainment ratio of 2. Oranges circles represent active cases in Winnipeg corrected with an ascertainment ratio of 2. Blue diamonds represent modeled shedding cases in Winnipeg, i.e. modeled active cases.